Navigation Links
ReShape Medical Announces Initiation of U.S. Clinical Study for Weight Loss

SAN CLEMENTE, Calif., March 3 /PRNewswire/ -- ReShape Medical™, Inc. announced today that it has initiated a U.S. Investigational Device Exemption (IDE) clinical study to assess the safety and effectiveness of its non-surgical, dual-balloon device for weight loss.  The ReShape Balloons are designed to be a treatment for the millions who want support with weight loss, without the invasiveness of surgery. The ReShape device occupies existing space in the stomach to reduce its capacity for food.  The balloons remain in place for six-months and are then removed.

The first U.S. study participant received the ReShape Balloons Treatment at The N.E.W. Program in Newport Beach, Calif., under the care of Brian Quebbemann, M.D., FACS, and Surgical Director of The N.E.W. Program.  "At 6'2" and 263 pounds, this 31-year old man did not qualify for bariatric surgery, and had exhausted his efforts with diets that didn't work," said Dr. Quebbemann.  

Dr. Quebbemann added, "Countless Americans have grown beyond a healthy weight and struggle with conventional methods of weight loss, but can't or won't undergo surgery.  This group is ideally suited for a non-surgical weight loss treatment such as the ReShape device being evaluated in this study."

"We are very pleased to initiate the U.S. IDE clinical study to evaluate the safety and efficacy of this emerging weight loss treatment.  There are millions of Americans who have a BMI over 30, but there are few options available to help them with their weight loss," said Bill Murray, President and CEO of ReShape Medical, Inc.  "We are pioneering the next-generation weight loss solution."

About ReShape Medical, Inc.

ReShape Medical is a development-stage medical device manufacturer headquartered in Southern California. The company is focused on the development of a non-surgical weight loss device that can be used as an aid in the treatment of obese or overweight patients.  

CAUTION--Investigational device.  Limited by United States law to investigational use.

For more information, please visit  

SOURCE ReShape Medical, Inc.

Back to top



SOURCE ReShape Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. As Biopharma Companies Reshape Sales Model, Most See Resetting Territory Size and Implementing Individualized Call Plans as First Steps Toward Change, According to New Research From Best Practices, LLC
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Globus Medical Raises $110 Million in Series E Financing Round
6. Quark Pharmaceuticals Appoints New Chief Medical Officer
7. Boston University Biomedical Engineers Find Chink in Bacterias Armor
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
10. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
11. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
Post Your Comments:
(Date:10/13/2015)... , Oct. 13, 2015 WuXi PharmaTech ... and technology platform company serving the pharmaceutical, biotechnology, ... has launched a mobile version of OncoWuXi, the ... to access oncology models and data on the ... and at any time to identify relevant tumor ...
(Date:10/13/2015)... 13, 2015 Health Gorilla ( ) today ... – a secure platform for clinical data and communications ... about and manage healthcare in the US. The launch follows ... a combined total of $4.4M raised to date, with ... True Ventures , Harris Barton , Orfin Ventures ...
(Date:10/13/2015)... DUBLIN , Oct. 8, 2015 Research ... of the "World Anti-counterfeit Pharmaceuticals and Cosmetics Packaging ... report to their offering. --> ... packaging market to grow at a CAGR of 15.7% ... The hologram authentication technology segment accounted for about ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... October 13, 2015 , ... Scientists in Seattle and Vancouver compared the ... with or without mesothelioma. Surviving Mesothelioma has just posted an article on the new ... Laboratories in Seattle and the University of British Columbia found that certain genetic alterations ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... establishment of telemedicine programs in communities throughout Georgia, along with affiliate organizations, Alabama ... schedule for their regional telehealth summits for Fall 2015. , Each of ...
(Date:10/13/2015)... ... 13, 2015 , ... California Southern University has named Dr. ... her Doctor of Nursing Practice from the renowned Johns Hopkins University—comes to CalSouthern ... Dr. McLeod’s long and successful nursing practice included a variety of patient care, ...
(Date:10/13/2015)... ... October 13, 2015 , ... Local Gold’s Gym franchise owner, ... Conference on August 26. Berry, who owns and operates Gold's Gym Cheyenne ... growing Gold’s Gyms in the United States. A brand leader in global fitness, Gold’s ...
(Date:10/13/2015)... ... October 13, 2015 , ... Breathing is ... do not breathe correctly. According to T’ai Chi (also spelled “Taiji”) and Qigong ... breathe correctly, in concert with the 7,000 year old tradition they teach, can ...
Breaking Medicine News(10 mins):